News

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...
A new breast cancer vaccine shows significant promise in preventing and treating the disease, particularly triple-negative ...
Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...
The development of the Covid vaccine helped super-charge what many researchers are calling an "mRNA-Renaissance" that could see new vaccines prevent everything from cancer to the plague.
Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...
Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.
In May, Ira Mellman, Genentech's vice president of cancer immunology, and his collaborators published a study in the journal Nature detailing the effect of their vaccine on 16 people with one of ...
A vaccine for pancreatic cancer is showing promise. Here's how it works. 05:25 When a routine scan led to Barbara Brigham's pancreatic cancer diagnosis in 2020, all she could think about was how ...
Duke researchers find potential in a cancer vaccine based on the same messenger RNA, or mRNA, technology used by COVID-19 vaccines to combat a type of breast cancer that over expresses a protein ...
A cancer vaccine is being tested in 800 pet dogs. If it works, researchers say it could one day be tested in humans.
Development of a cancer vaccine may be accelerated by BioNTech's COVID work. LONDON -- The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer ...
A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.